ID   AGS/EPI
AC   CVCL_Y085
DR   Wikidata; Q54748717
RX   PubMed=25169536;
CC   Selected for resistance to: ChEBI; CHEBI:47898; 4'-epidoxorubicin (Epirubicin).
CC   Sequence variation: Heterozygous for CTNNB1 p.Gly34Glu (c.101G>A) (from parent cell line).
CC   Sequence variation: Heterozygous for KRAS p.Gly12Asp (c.35G>A) (ClinVar=VCV000012582) (from parent cell line).
CC   Sequence variation: Heterozygous for PIK3CA p.Glu453Lys (c.1357G>A) (ClinVar=VCV000376470) and p.Glu545Ala (c.1634A>C) (from parent cell line).
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 02-07-20; Version: 6
//
RX   PubMed=25169536; DOI=10.7314/APJCP.2014.15.16.6849;
RA   Felipe A.V., Moraes A.A., de Oliveira J., da Silva T.D., Forones N.M.;
RT   "Establishment and partial characterization of an epirubicin-resistant
RT   gastric cancer cell line with upregulated ABCB1.";
RL   Asian Pac. J. Cancer Prev. 15:6849-6853(2014).
//